target therapy current limit patient hepatocellular carcinoma cc due lack suitable target kind play pivot role mani cellular biology process where dysregul may lead various disease particularly cancer howe role align remain unclear studi employ kino small inter rna sina library comprise kinaserel gene screen whether essential cell provider line screen found map crucial gene pharmacology gene about diminish growth migrate ideas cell include primary stable lockdown attend tumor format steroid culture model xenograft mouse admit silent reduce phosphorus express mammalian target rapamycin motor post correct tumor higher express significantly assoc poor prognosis taken together result reveal mapkmtor ai might promote tumorigenesi provide potent marker therapeutic 